| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/16/1992 | US5122603 Purified insulin mediators and purification process for same |
| 06/16/1992 | US5122543 Syrup of carbamazepine in protective polymeric colloid |
| 06/16/1992 | US5122542 Hypotriglyceridemic use of certain bis (3,5-di-alkyl-4-hydroxyphenylthio)methanes |
| 06/16/1992 | US5122540 Method and composition for treating warts and throat soreness with DMSO and citric acid |
| 06/16/1992 | US5122537 Tyrosine kinase inhibitors |
| 06/16/1992 | US5122536 Applying calcium or magnesium ascorbate or esters or or anhydrides of ascorbic acid |
| 06/16/1992 | US5122535 Method of solubilizing melatonine in water |
| 06/16/1992 | US5122534 Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides |
| 06/16/1992 | US5122533 Psoriasis treatment, applying substituted thiol compound and allantoin |
| 06/16/1992 | US5122528 Analgesic use of benzobicyclic carboxamides |
| 06/16/1992 | US5122525 Pyrido(1,2-A) pyrazines |
| 06/16/1992 | US5122524 Triazinone compounds compositions thereof and metal of use |
| 06/16/1992 | US5122523 N-acylamino acid derivatives and their pharmaceutical compositions |
| 06/16/1992 | US5122522 Treatment and control of ocular development |
| 06/16/1992 | US5122519 Tetracyclines in solvent, gelling vehicle |
| 06/16/1992 | US5122514 Psoriasis treatment |
| 06/16/1992 | US5122512 Swine growth promoting composition |
| 06/16/1992 | US5122461 Preparation of pyrocatecholic compounds |
| 06/16/1992 | US5122382 Transdermal contraceptive formulations, methods and devices |
| 06/16/1992 | US5122368 Anthracycline conjugates having a novel linker and methods for their production |
| 06/16/1992 | US5122301 Antimicrobial compositions containing propylene carbonate and/or ethylene carbonate as the carrier solvent |
| 06/16/1992 | US5122127 Apparatus and methods for use in administering medicaments by direct medicament contact to mucosal tissues |
| 06/16/1992 | CA2057651A1 Agistatins, novel metabolites from fusarium sp., a process for their preparation, and their use |
| 06/16/1992 | CA1303619C Alkoxy derivatives of ginkgolides, their preparation and therapeutic compositions containing the same |
| 06/16/1992 | CA1303616C N-1-azabicyclo¬2,2,2|-oct-3yl)-benzamide compounds |
| 06/16/1992 | CA1303613C Substituted indoloquinoxalines |
| 06/16/1992 | CA1303607C 6.alpha.-METHYLCORTICOIDS AND THEIR MANUFACTURE AND USE |
| 06/16/1992 | CA1303510C Stable aqueous solution of vincristine sulfate |
| 06/16/1992 | CA1303509C Pharmaceutical compositions containing levodopa methyl ester, preparation and therapeutic applications thereof |
| 06/16/1992 | CA1303508C Use of dihydro benzopyran derivatives |
| 06/16/1992 | CA1303507C Anti-inflammatory compositions |
| 06/16/1992 | CA1303506C Dry powdered germicide and healing composition containing allantoin and ascorbic acid |
| 06/16/1992 | CA1303505C Anti-tumor compositions containing 5, 5-dimethyl-2- phenyl-4-thiazolidine carboxylic acid or 5, 5- dimethyl-2-(2-hydroxyphenyl)-4-thiazolidine carboxylic acid |
| 06/16/1992 | CA1303504C Pharmaceutical formulation containing acrivastine |
| 06/16/1992 | CA1303502C Sustained release pharmaceutical compositions in oral dosage form |
| 06/16/1992 | CA1303498C Composition and method for treatment of copper deficiency |
| 06/16/1992 | CA1303497C Modification of plant extracts from zygophyllaceae |
| 06/15/1992 | CA2057534A1 Acid amides |
| 06/15/1992 | CA2057511A1 Biphenylyl compounds |
| 06/15/1992 | CA2056835A1 Hydrophilic form of perfluoro compounds and methods of manufacture |
| 06/14/1992 | WO1992010494A1 Pharmaceuticals |
| 06/14/1992 | WO1992010190A1 Novel csaids |
| 06/14/1992 | CA2098309A1 Pharmaceuticals |
| 06/14/1992 | CA2098177A1 Csaids |
| 06/14/1992 | CA2057601A1 Pharmaceutical use of diamino acid derivatives |
| 06/14/1992 | CA2057524A1 Dihydro-isoquinoline derivatives |
| 06/14/1992 | CA2057357A1 Substituted dibenz-oxa-thiocinones, -12-oxides and -12, 12-dioxides, a process for their preparation and their use in medicaments |
| 06/14/1992 | CA2056582A1 1,2,3,6-tetrahydropyridine derivatives |
| 06/13/1992 | WO1992010469A1 Hydroxamic acid derivatives which inhibit lipoxygenase |
| 06/13/1992 | CA2094247A1 Hydroxamic acid derivatives which inhibit lipoxygenase |
| 06/13/1992 | CA2057138A1 Aminoalkyl ketone derivatives, process for preparing them and their use in therapy |
| 06/12/1992 | WO1992010502A1 Heterocyclic carboxylic esters, methods for their preparation and their use for the preparation of gastro-intestinal medicines |
| 06/12/1992 | WO1992010479A1 Amidic derivatives of glutamic, aspartic and 2-amino adipic acids with antigastrin activity |
| 06/12/1992 | WO1992010476A1 N-substituted lactams useful as cholecystokinin antagonists |
| 06/12/1992 | WO1992010464A1 4,5-dihydroxy- and 4,5,8-trihydroxy- 9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid dicarbonates and urethans having therapeutical activities |
| 06/12/1992 | CA2098112A1 4,5-dihydroxy- and 4,5,8-trihydroxy- 9,10-dioxo-2-anthracenecarboxylic acid dicarbonates and urethans having therapeutical activities |
| 06/12/1992 | CA2097517A1 N-substituted lactams useful as cholecystokinin antagonists |
| 06/12/1992 | CA2097069A1 Amidic derivatives of glutamic, aspartic and 2-amino adipic acids with antigastrin activity |
| 06/12/1992 | CA2075812A1 Heterocyclic carboxylic esters, methods for their preparation and their use for the preparation of gastro-intestinal medicines |
| 06/12/1992 | CA2057475A1 3'-(2')-amino- or thiol-modified, fluorescent dye-coupled nucleosides, nucleotides and oligonucleotides, and a process for the preparation and the use thereof |
| 06/11/1992 | WO1992010193A2 Homo-prostaglandin derivatives as ocular hypotensives |
| 06/11/1992 | WO1992009926A1 Storage phosphor cassette assembly |
| 06/11/1992 | WO1992009619A1 2β,19-METHYLENEAMINO BRIDGED STEROIDS AS AROMATASE INHIBITORS |
| 06/11/1992 | WO1992009610A1 Drug delivery porphyrin compositions and methods |
| 06/11/1992 | WO1992009607A1 Ecteinascidins 736 and 722 |
| 06/11/1992 | WO1992009600A1 Benzofuran and benzthiophene derivatives |
| 06/11/1992 | WO1992009598A1 New pyridine derivatives, methods of preparing them and their use as drugs |
| 06/11/1992 | WO1992009597A1 Optical isomers of 7-[3-(1,1-dialkylmethyl-1-amino-1-pyrrolidinyl]-quinolones and naphthyridones as antibacterial agents |
| 06/11/1992 | WO1992009596A1 Individual stereoisomers of 7-[3-(1-aminoalkyl)-1-pyrrolidinyl]-quinolones and naphthyridones as antibacterial agents |
| 06/11/1992 | WO1992009589A1 Method for preparing taxane derivatives, novel derivatives thereby obtained and pharmaceutical compositions containing same |
| 06/11/1992 | WO1992009583A1 Novel pilocarpine derivatives and process for their preparation |
| 06/11/1992 | WO1992009567A1 Anti-inflammatory compounds |
| 06/11/1992 | WO1992009566A1 Novel hydroxamic acid and n-hydroxyurea derivatives and their use |
| 06/11/1992 | WO1992009563A1 Improved matrix metalloprotease inhibitors |
| 06/11/1992 | WO1992009561A1 New amide derivatives |
| 06/11/1992 | WO1992009557A1 Benzenedimethanol suitable for micronisation |
| 06/11/1992 | WO1992009553A1 Water-soluble pentacyclic triterpene composition and production thereof |
| 06/11/1992 | WO1992009308A1 Complexes of the active enantiomer of ibuprofene with cyclodextrin |
| 06/11/1992 | WO1992009301A1 Tissue sealant and growth factor containing compositions that promote accelerated wound healing |
| 06/11/1992 | WO1992009297A1 Hiv protease inhibitors |
| 06/11/1992 | WO1992009289A1 Diaper rash treatment |
| 06/11/1992 | WO1992009285A1 Combinations of vanilloid compounds and phosphonate antiviral compounds for treatment of herpes infections |
| 06/11/1992 | WO1992009282A1 Treatment for tissue ulceration |
| 06/11/1992 | WO1992009279A1 2-arylthiazole derivative and pharmaceutical composition containing the same |
| 06/11/1992 | WO1992009278A1 Substituted 5-aryl imidazoles |
| 06/11/1992 | WO1992009277A1 Nutrient supply |
| 06/11/1992 | WO1992009273A1 Retarded-action urapidil formulation |
| 06/11/1992 | WO1992009272A1 Method and composition for controlled delivery of biologically active agents |
| 06/11/1992 | WO1992009271A1 Composition for solid pharmaceutical preparations containing active vitamins d3 and process for preparation thereof |
| 06/11/1992 | WO1992009268A1 Prevention of synovial adhesions |
| 06/11/1992 | WO1992009259A1 Stimulation of hair growth with potassium channel openers and an androgen receptor blocker |
| 06/11/1992 | WO1992009202A1 Control of parasitic nematodes (a) |
| 06/11/1992 | WO1992007832A3 Substituted piperazines as central nervous system agents |
| 06/11/1992 | WO1992002534A3 Compounds and methods for inhibiting gene expression |
| 06/11/1992 | WO1991015498A3 Nucleoside derivatives |
| 06/11/1992 | DE4109508C1 2-phenyl-1,2-benz:iso:selenazol-3(2H)-1-one - used for treating diabetes and diseases caused by inflammation of islet cells |
| 06/11/1992 | DE4042437A1 Topical compsn. for treating burns - contg. omega-3-fatty acid esp. eicosa-penta:enoic acid as fish oil component, providing rapid healing |
| 06/11/1992 | DE4039559A1 Funktionalisierte vinylazole, verfahren zu deren herstellung, pharmazeutische praeparate die diese vinylazole enthalten sowie deren verwendung zur herstellung von arzneimitteln Functionalized vinylazoles, processes for their preparation, pharmaceutical compositions containing them and their use for vinylazoles preparation of medicaments |
| 06/11/1992 | DE4038692A1 Agent for treating eye disorders esp. grey star - consists of demineralised sterilised water contg. urea and/or other substances, such as glycol, animal protein, plant extracts etc. |
| 06/11/1992 | CA2099603A1 New pyridine derivatives, processes for their preparation and use as medicaments |